ALS Canada has named 39 Canadians to receive the King Charles III Coronation Medal for their efforts into research and advocacy for ALS.

$15 million grant supports the development of antisense oligonucleotide (ASO) therapeutics for ultra-rare genetic forms of ALS through the Silence ALS Initiative The FDA has approved the treatment ...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the publication of new preclinical research in Free Radical Biology and Medicine, highlighting the role of edaravone in mitigating TDP-43 ...

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing ...

SineuGene Therapeutics Co., Ltd. ("SineuGene"), a clinical-stage biotech company pioneering innovative therapies for neurological disorders, today announced that the U.S. Food and Drug Administration ...

Currently, there is no known cure for ALS. ALS affects approximately 50,000 people in the U.S. and Europe, with over 5,000 new cases diagnosed annually. With limited treatment options available, the ...

Results demonstrated statistically significant effects on biomarkers that predict ALS disease progression and severity Evidence of brain pe ...

Currently, terminally ill Montanans can obtain life-ending prescriptions under a legal loophole. One bill to ban the practice ...

In this week’s InnovationRx newsletter, the worsening measles outbreak, a noninvasive brain-computer implant, replacing heart ...

EQT Foundation opens applications for deeptech solutions tackling female-specific health challenges worldwide, with a focus on funding breakthrough scientific innovationThe grants program will ...